23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Orange</strong> <strong>Guide</strong> – Chapter 6: Clinical Research <strong>and</strong> Investigator-Initiated Research<br />

As with other financial transactions that occur between <strong>Pfizer</strong> <strong>and</strong> HCPs, attempting to influence an<br />

HCP’s prescribing behavior by providing money for research is illegal. The impact on an HCP’s<br />

prescribing behavior must not be taken into consideration when deciding whether to engage him or her<br />

as an investigator, or fund or support his or her independent medical research.<br />

All requests for medical research support must be referred to <strong>Pfizer</strong> Medical Colleagues. <strong>Pfizer</strong> requires<br />

investigators to submit requests for IIR grants through the IIR submission portal at www.pfizer.com/IIR.<br />

Multi-disciplinary teams review IIR proposals for medical <strong>and</strong> scientific merit <strong>and</strong> study feasibility.<br />

Non-compliance with policies applicable to those activities puts the Company at risk <strong>and</strong> can<br />

subject <strong>Pfizer</strong> colleagues to disciplinary actions up to <strong>and</strong> including termination.<br />

Key Points to Ensure Compliance<br />

All decisions to engage a physician as a clinical investigator or to provide support for an IIR<br />

study must be made by colleagues in a medical, clinical or scientific function.<br />

Funding or other support for medical research may never be provided to:<br />

o Establish or improve <strong>Pfizer</strong>’s relationship with an HCP;<br />

o Gain or improve access to an HCP;<br />

o Reward past prescribing or induce future prescribing; or<br />

o Influence an upcoming formulary decision or reward a past formulary decision.<br />

Do not attempt to influence a decision by <strong>Pfizer</strong>’s Medical Division to hire clinical investigators<br />

or award grants for IIR based on the potential impact to <strong>Pfizer</strong> sales.<br />

Do not provide starters (samples) to HCPs for use in clinical trials.<br />

Types of Funding or Support<br />

<strong>Pfizer</strong> will only fund <strong>and</strong> support legitimate medical research. Such research must seek to answer a<br />

genuine scientific or clinical question through the researcher’s active scientific pursuit. The researcher<br />

must be qualified to conduct the intended research, <strong>and</strong> be selected on the basis of his or her applicable<br />

116<br />

Rev. 09/12<br />

Page 3 of 9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!